Literature DB >> 18287101

The ATPase cycle of the mitochondrial Hsp90 analog Trap1.

Adriane Leskovar1, Harald Wegele, Nicolas D Werbeck, Johannes Buchner, Jochen Reinstein.   

Abstract

Hsp90 is an ATP-dependent molecular chaperone whose mechanism is not yet understood in detail. Here, we present the first ATPase cycle for the mitochondrial member of the Hsp90 family called Trap1 (tumor necrosis factor receptor-associated protein 1). Using biochemical, thermodynamic, and rapid kinetic methods we dissected the kinetics of the nucleotide-regulated rearrangements between the open and the closed conformations. Surprisingly, upon ATP binding, Trap1 shifts predominantly to the closed conformation (70%), but, unlike cytosolic Hsp90 from yeast, this process is rather slow at 0.076 s(-1). Because reopening (0.034 s(-1)) is about ten times faster than hydrolysis (k(hyd) = 0.0039 s(-1)), which is the rate-limiting step, Trap1 is not able to commit ATP to hydrolysis. The proposed ATPase cycle was further scrutinized by a global fitting procedure that utilizes all relevant experimental data simultaneously. This analysis corroborates our model of a two-step binding mechanism of ATP followed by irreversible ATP hydrolysis and a one-step product (ADP) release.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18287101     DOI: 10.1074/jbc.M709516200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  44 in total

1.  Paralog-selective Hsp90 inhibitors define tumor-specific regulation of HER2.

Authors:  Pallav D Patel; Pengrong Yan; Paul M Seidler; Hardik J Patel; Weilin Sun; Chenghua Yang; Nanette S Que; Tony Taldone; Paola Finotti; Ralph A Stephani; Daniel T Gewirth; Gabriela Chiosis
Journal:  Nat Chem Biol       Date:  2013-09-01       Impact factor: 15.040

2.  Spatially and kinetically resolved changes in the conformational dynamics of the Hsp90 chaperone machine.

Authors:  Christian Graf; Marta Stankiewicz; Günter Kramer; Matthias P Mayer
Journal:  EMBO J       Date:  2009-01-22       Impact factor: 11.598

3.  Hsp90 inhibitors as senolytic drugs to extend healthy aging.

Authors:  Heike Fuhrmann-Stroissnigg; Laura J Niedernhofer; Paul D Robbins
Journal:  Cell Cycle       Date:  2018-07-23       Impact factor: 4.534

4.  The charged linker region is an important regulator of Hsp90 function.

Authors:  Otmar Hainzl; Maria Claribel Lapina; Johannes Buchner; Klaus Richter
Journal:  J Biol Chem       Date:  2009-06-24       Impact factor: 5.157

5.  Molecular mechanism of bacterial Hsp90 pH-dependent ATPase activity.

Authors:  Yi Jin; Reyal S Hoxie; Timothy O Street
Journal:  Protein Sci       Date:  2017-04-20       Impact factor: 6.725

6.  Control of tumor bioenergetics and survival stress signaling by mitochondrial HSP90s.

Authors:  Young Chan Chae; M Cecilia Caino; Sofia Lisanti; Jagadish C Ghosh; Takehiko Dohi; Nika N Danial; Jessie Villanueva; Stefano Ferrero; Valentina Vaira; Luigi Santambrogio; Silvano Bosari; Lucia R Languino; Meenhard Herlyn; Dario C Altieri
Journal:  Cancer Cell       Date:  2012-09-11       Impact factor: 31.743

7.  Dissection of the ATP-induced conformational cycle of the molecular chaperone Hsp90.

Authors:  Martin Hessling; Klaus Richter; Johannes Buchner
Journal:  Nat Struct Mol Biol       Date:  2009-02-22       Impact factor: 15.369

8.  5'-N-ethylcarboxamidoadenosine is not a paralog-specific Hsp90 inhibitor.

Authors:  Shanshan Liu; Timothy O Street
Journal:  Protein Sci       Date:  2016-10-04       Impact factor: 6.725

9.  The complex dance of the molecular chaperone Hsp90.

Authors:  Len Neckers; Mehdi Mollapour; Shinji Tsutsumi
Journal:  Trends Biochem Sci       Date:  2009-04-07       Impact factor: 13.807

10.  A common conformationally coupled ATPase mechanism for yeast and human cytoplasmic HSP90s.

Authors:  Cara K Vaughan; Peter W Piper; Laurence H Pearl; Chrisostomos Prodromou
Journal:  FEBS J       Date:  2008-11-20       Impact factor: 5.542

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.